HCV‐specific T cells in HCV/HIV co‐infection show elevated frequencies of dual Tim‐3/PD‐1 expression that correlate with liver disease progression
暂无分享,去创建一个
R. Kaul | M. Ostrowski | C. Kovacs | K. Clayton | F. Yue | R. B. Jones | M. Klein | D. Wong | P. Sheth | A. Sakhdari | S. Saeed | E. Benko | G. Gyenes | B. Vali
[1] T. Heeren,et al. Noninvasive Markers of Liver Fibrosis Are Highly Predictive of Liver-Related Death in a Cohort of HCV-Infected Individuals With and Without HIV Infection , 2010, The American Journal of Gastroenterology.
[2] R. Sterling,et al. Systematic review: non‐invasive methods of fibrosis analysis in chronic hepatitis C , 2009, Alimentary pharmacology & therapeutics.
[3] R. Koup,et al. Differential Association of Programmed Death-1 and CD57 with Ex Vivo Survival of CD8+ T Cells in HIV Infection1 , 2009, The Journal of Immunology.
[4] B. McMahon,et al. Negative Immune Regulator Tim-3 Is Overexpressed on T Cells in Hepatitis C Virus Infection and Its Blockade Rescues Dysfunctional CD4+ and CD8+ T Cells , 2009, Journal of Virology.
[5] G. Freeman,et al. Synergistic Reversal of Intrahepatic HCV-Specific CD8 T Cell Exhaustion by Combined PD-1/CTLA-4 Blockade , 2009, PLoS pathogens.
[6] R. Kaul,et al. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection , 2008, The Journal of experimental medicine.
[7] R. Kaul,et al. HIV-Specific T-Cells Accumulate in the Liver in HCV/HIV Co-Infection , 2008, PloS one.
[8] R. Kaul,et al. Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation. , 2008, The Journal of infectious diseases.
[9] N. Afdhal,et al. Diagnosis and quantitation of fibrosis. , 2008, Gastroenterology.
[10] Todd M. Allen,et al. Antigen Load and Viral Sequence Diversification Determine the Functional Profile of HIV-1–Specific CD8+ T Cells , 2008, PLoS medicine.
[11] T. Wilson,et al. The utility of aspartate aminotransferase/platelet ratio index in HIV/hepatitis C-co-infected patients , 2007, AIDS.
[12] Todd M. Allen,et al. Impaired Hepatitis C Virus-Specific T Cell Responses and Recurrent Hepatitis C Virus in HIV Coinfection , 2006, PLoS medicine.
[13] R. Koup,et al. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection , 2006, The Journal of experimental medicine.
[14] Philip J. R. Goulder,et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression , 2006, Nature.
[15] M. Massari,et al. PD-1 Expression in Acute Hepatitis C Virus (HCV) Infection Is Associated with HCV-Specific CD8 Exhaustion , 2006, Journal of Virology.
[16] C. Cooper,et al. Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus‐coinfected patients , 2005, HIV medicine.
[17] C. Walker,et al. Adaptive immune responses in acute and chronic hepatitis C virus infection , 2005, Nature.
[18] R. Khanna,et al. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. , 2004, The Lancet. Infectious diseases.
[19] C. Walker,et al. Cell-mediated immunity and the outcome of hepatitis C virus infection. , 2004, Annual review of microbiology.
[20] J. Kalbfleisch,et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C , 2003, Hepatology.
[21] J. Ghrayeb,et al. Memory CD8+ T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection , 2003, The Journal of experimental medicine.
[22] J. Hoofnagle,et al. Impaired Effector Function of Hepatitis C Virus-Specific CD8+ T Cells in Chronic Hepatitis C Virus Infection1 , 2002, The Journal of Immunology.
[23] M. Lederman,et al. HIV long-term non-progressors maintain brisk CD8 T cell responses to other viral antigens , 2002, AIDS.
[24] E. Rosenberg,et al. Human Immunodeficiency Virus Type 1-Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses , 2002, Journal of Virology.
[25] J. Lieberman,et al. Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection. , 2000, Blood.
[26] B. Walker,et al. Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus , 2000, The Journal of experimental medicine.
[27] P. Schmid,et al. Patients co‐infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA , 1999, Journal of viral hepatitis.
[28] J. Altman,et al. Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function , 1998, The Journal of experimental medicine.
[29] D. Vlahov,et al. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. , 1996, The Journal of infectious diseases.
[30] M. Urdea,et al. Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections , 1993, Journal of clinical microbiology.
[31] E. Strauss,et al. Use of AST platelet ratio index (APRI Score) as an alternative to liver biopsy for treatment indication in chronic hepatitis C. , 2009, Annals of hepatology.
[32] C. Soderberg-Naucler. Human cytomegalovirus persists in its host and attacks and avoids elimination by the immune system. , 2006, Critical reviews in immunology.
[33] J. Lieberman,et al. Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic. , 2003, Blood.